Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis

J Int Med Res. 2023 Jun;51(6):3000605231182557. doi: 10.1177/03000605231182557.

Abstract

Objective: To investigate the relationships of leukemia inhibitory factor receptor (LIFR) with cervical cancer invasion and metastasis.

Methods: From January 2021 to December 2022, 45 patients treated for cervical cancer and lung metastases were identified. Western blotting was used to determine the expression of Hippo-YAP signaling pathway-related proteins. Meanwhile, 40 healthy Sprague-Dawley nude mice were used and evenly randomized into two groups, which were injected with LIFR-overexpressing (study group) or normal cervical cancer cells (control group). The lung tissue of nude mice was removed for hematoxylin-eosin staining, and the number of lung cell metastases in nude mice was counted.

Results: The highest LIFR mRNA expression was found in paracancerous tissue, followed by cervix cancer tissue and metastatic lesions. The study group exhibited higher LIFR, P-YAP, and P-TAZ protein expression and lower YAP and TAZ protein expression than the control group. The study group had a lower number of lung metastases than the control group.

Conclusion: Decreased expression of LIFR and decreased phosphorylation of Hippo-YAP signaling pathway-related proteins might be the underlying mechanisms that promote lung metastasis of cervical cancer.

Keywords: Leukemia inhibitory factor receptor; cervical cancer; invasion; lung metastasis; mechanism of action; migration.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Humans
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / metabolism
  • Mice
  • Mice, Nude
  • Receptors, OSM-LIF
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Receptors, OSM-LIF
  • LIFR protein, human